Biomarkers: Difference between revisions

    From Longevity Wiki
    No edit summary
    No edit summary
    Line 1: Line 1:
    {{Stub}}
    {{Stub}}
    *{{pmid_text|37923875}}
    *{{pmid_text|37923875}}
    * {{pmid text|34093670}}
    *{{pmid text|34093670}}
    *


    == TOP 5 Biomarkers For Longevity ==
    == TOP 5 Biomarkers For Longevity ==

    Revision as of 20:53, 6 November 2023

       This article is a stub. You can help by expanding it.
    
    • 2023, Correction to: Blood biomarker profiles and exceptional longevity: comparison of centenarians and non‑centenarians in a 35‑year follow‑up of the Swedish AMORIS cohort [1]
    • 2021, Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring [2]

    TOP 5 Biomarkers For Longevity

    Biomarker
    Glucose Level HbA1c
    Inflammatory markers, especially cardiovascular like CRP should be low
    Cholesterol markers including Lipoprotein(a)
    Hormone levels (testosterone)
    Albumin

    References

    1. Murata S et al.: Correction to: Blood biomarker profiles and exceptional longevity: comparison of centenarians and non‑centenarians in a 35‑year follow‑up of the Swedish AMORIS cohort. Geroscience 2023. (PMID 37923875) [PubMed] [DOI]
    2. Hartmann A et al.: Ranking Biomarkers of Aging by Citation Profiling and Effort Scoring. Front Genet 2021. (PMID 34093670) [PubMed] [DOI] [Full text] Aging affects most living organisms and includes the processes that reduce health and survival. The chronological and the biological age of individuals can differ remarkably, and there is a lack of reliable biomarkers to monitor the consequences of aging. In this review we give an overview of commonly mentioned and frequently used potential aging-related biomarkers. We were interested in biomarkers of aging in general and in biomarkers related to cellular senescence in particular. To answer the question whether a biological feature is relevant as a potential biomarker of aging or senescence in the scientific community we used the PICO strategy known from evidence-based medicine. We introduced two scoring systems, aimed at reflecting biomarker relevance and measurement effort, which can be used to support study designs in both clinical and research settings.